Skip to content

Erythromycin

by Oxoid Ltd 2 variants

Ref CT0021B

Erythromycin (CT0021B) is a device classified as IVD General made by Oxoid Ltd, registered in EUDAMED on 25 Aug 2026 (Basic UDI-DI B-05032384005666), active as of 24 Oct 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-05032384005666 Basic UDI-DI 05032384005666UDI-DIDate25 Aug 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Model / reference
CT0021B
Primary DI / UDI-DI
05032384005666
Basic UDI-DI
B-05032384005666
EMDN code
W0104080502 Impregnated disks, multi-disks & tablets
Device class
Class IVD General
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands

Manufacturer details

EUDAMED SRN
GB-MF-000016914
Authorised representative
Thermo Fisher Diagnostics B.V. NL-AR-000013157

Similar devices in this category

Other devices filed under IMPREGNATED DISKS, MULTI-DISKS & TABLETS.

Other devices from Oxoid Ltd

See all devices from Oxoid Ltd →

Properties

  • Contains substances of microbial origin
  • Reagent
  • Professional testing
Other properties (9, all answered No)